Prospective Evaluation of Artificial Intelligence-enabled Screening for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Prospective Evaluation of Artificial Intelligence-enabled Screening for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)	cardiovascular disorder, heart disorder, heart failure	Enrolling by invitation	Not stated	2026-08-18		NCT07398950

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bridgebio Pharma, Inc	2
Yale University	458

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Yale New Haven Health System	New Haven	United States	4

Clinical trials